XC-627

N/A

Report date: 2022/04/26 17:27:00
NME

Base Information

Drug NameXC-627
Drug Alias NameXC-627
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor modulatorsCysteinyl leukotriene receptor 1 modulators
TargetsBeta-2 adrenergic receptorCysteinyl leukotriene receptor 1
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwest University
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A